Comerica Incorporated

NYSE:CMA Lagerbericht

Marktkapitalisierung: US$11.3b

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Comerica Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Der Gewinn von Comerica wird voraussichtlich um 1.3% pro Jahr zurückgehen, während der Jahresumsatz um 2% pro Jahr wachsen soll. Der Gewinn je Aktie wird voraussichtlich um 1.1% pro Jahr steigen. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 9.4% betragen.

Wichtige Informationen

-1.3%

Wachstumsrate der Gewinne

1.12%

EPS-Wachstumsrate

Banks Gewinnwachstum8.2%
Wachstumsrate der Einnahmen2.0%
Zukünftige Eigenkapitalrendite9.40%
Analystenabdeckung

Good

Zuletzt aktualisiert03 Feb 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Narrativ-Update Jan 25

CMA: Merger Approvals And Integration Progress Will Shape Fairly Balanced Outlook

Narrative Update The analyst price target for Comerica has moved higher from US$81.28 to US$88.75, with analysts pointing to recent target increases, ratings upgrades, and expectations around the Fifth Third acquisition as key drivers of their updated views. Analyst Commentary Recent research on Comerica clusters around two themes: the pending acquisition by Fifth Third and how regional banks stack up against larger peers.
Narrativ-Update Jan 11

CMA: Fifth Third Deal And Higher P/E Multiple Will Drive Repricing

Analysts have lifted their fair value estimate for Comerica to about $113.47 from $99.00, citing higher Street price targets, recent upgrades related to the pending Fifth Third acquisition, and updated assumptions that include a higher future P/E multiple, even as revenue growth and profit margin expectations are more restrained. Analyst Commentary Bullish analysts are leaning more constructive on Comerica following the announced acquisition by Fifth Third, with several research updates pointing to improved sentiment on both valuation and deal execution.
Narrativ-Update Dec 27

CMA: Fifth Third Merger Will Drive Repricing And Earnings Outlook Through 2027

Analysts have nudged their fair value estimate for Comerica higher, lifting the target from $97.00 to $99.00 as they factor in the Fifth Third acquisition, modestly stronger revenue growth and profitability assumptions, and a higher future earnings multiple reflecting anticipated deal accretion and improved banking sector sentiment. Analyst Commentary Street research surrounding Comerica has shifted meaningfully more constructive following the announced merger with Fifth Third, with several bullish analysts revisiting ratings and valuation frameworks.
Narrativ-Update Dec 13

CMA: Fifth Third Merger Will Reframe Earnings Outlook And Trading Dynamics

Analysts have lifted their fair value estimate for Comerica to $97 from about $71, reflecting higher expected revenue growth and valuation multiples as the Fifth Third stock merger reshapes the bank's earnings outlook and trading dynamics. Analyst Commentary Recent Street research reflects a meaningful shift in sentiment toward Comerica following the announced all stock acquisition by Fifth Third, with several bullish analysts revising ratings and price targets higher to reflect the new strategic and valuation framework.
Narrativ-Update Nov 29

CMA: Merger Will Shift Share Focus While Integration And Board Actions Remain Key

Comerica's average analyst price target has increased, with analysts citing the anticipated benefits and strategic rationale of the recently announced merger with Fifth Third as the primary drivers for the upward revision. Analyst Commentary Following the announcement of the merger between Comerica and Fifth Third, analysts have provided a range of perspectives on the outlook for Comerica shares.
Narrativ-Update Nov 15

CMA: Outlook Will Balance Merger Synergies With Execution And Integration Risks

Analysts have modestly increased their price target for Comerica from $79.78 to $81.28. This reflects renewed optimism following the announced merger with Fifth Third and supportive M&A trends within the sector.
Narrativ-Update Nov 01

CMA: Fifth Third Merger Will Shape Sunbelt Reach And Influence Future Performance

Comerica's fair value estimate has been raised from $75.05 to $79.78. Analysts cite anticipated benefits from the recently announced merger with Fifth Third and the resulting upward revisions to price targets.
Narrativ-Update Oct 18

Sunbelt And Digital Focus Will Define Future Strength

Comerica's analyst price target has increased from $69 to $75.05. Analysts highlight the supportive impact of the pending merger with Fifth Third Bancorp and updated valuation frameworks.
Narrativ-Update Oct 03

Sunbelt And Digital Focus Will Define Future Strength

Comerica’s analyst price target increased from $67.38 to $69.00, as analysts cite improving net interest income projections and a more constructive operating environment for mid-cap banks. Analyst Commentary Recent Street research on Comerica highlights a mix of optimistic and cautious views among analysts, reflecting both improved expectations for bank fundamentals and some persistent risks facing the sector.
Narrativ-Update Sep 11

Sunbelt And Digital Focus Will Define Future Strength

Analysts have raised Comerica’s price target slightly to $67.38, reflecting expectations of a constructive macro environment, improved loan growth, potential M&A, and relative valuation appeal for capital-strong regional banks. Analyst Commentary Expectations of a constructive macro backdrop supporting banking fundamentals, loan growth acceleration in the second half, and potential M&A activity.
Analyseartikel Aug 27

Comerica (NYSE:CMA) Is Paying Out A Dividend Of $0.71

The board of Comerica Incorporated ( NYSE:CMA ) has announced that it will pay a dividend of $0.71 per share on the 1st...
Seeking Alpha Aug 19

CMA.PR.B: 6.875% Fixed Rate Reset Preferred IPO From Comerica Incorporated

Summary CMA.PR.B offers a 6.875% fixed, non-cumulative dividend, resetting in 2030, with favorable tax treatment, and strong dividend coverage from Comerica's common equity. Comerica's credit profile has been unchanged since 2020, but faces a negative outlook due to funding and liquidity pressures, though preferred dividend risk appears minimal for now. The preferred stock trades at a significant credit spread premium versus company debt, suggesting attractive relative value for income-focused investors. Relative sector valuation shows CMA-B is fairly priced versus peers, but I prefer higher-quality alternatives like BOH-B and RF-F for better risk/reward. I see no immediate concerns for CMA-B holders, but I will monitor for a more attractive entry point before considering an investment. Read the full article on Seeking Alpha
Analyseartikel Aug 02

Comerica (NYSE:CMA) Has Announced A Dividend Of $0.71

The board of Comerica Incorporated ( NYSE:CMA ) has announced that it will pay a dividend of $0.71 per share on the 1st...
Analyseartikel Jun 11

Comerica (NYSE:CMA) Is Due To Pay A Dividend Of $0.71

Comerica Incorporated ( NYSE:CMA ) has announced that it will pay a dividend of $0.71 per share on the 1st of July. The...
Analyseartikel May 27

Comerica (NYSE:CMA) Is Paying Out A Dividend Of $0.71

Comerica Incorporated ( NYSE:CMA ) will pay a dividend of $0.71 on the 1st of July. This makes the dividend yield 5.1...
Seeking Alpha Apr 21

Comerica Q1 Earnings Review: Deposit Weakness Offsets Solid Credit Quality

Summary Comerica Incorporated's Q1 results showed solid credit quality but weak deposit trends, with average deposits falling by $1.4 billion and a significant 5% annual decline. Despite cutting deposit costs aggressively, Comerica's strategy to maximize margins may hinder deposit growth, especially with the loss of the Direct Express contract. Loan demand remains soft, with average balances down $400 million, and commercial real estate exposure declining by $250 million amid economic uncertainty. Given average capital and poor deposit trends, I rate CMA stock as a hold, expecting shares to remain in the low-$50s, with limited upside potential. Read the full article on Seeking Alpha
Seeking Alpha Jan 27

Comerica: Deposit Pressures Reflected After A Mixed Q4 (Rating Upgrade)

Summary Comerica's shares have been mixed, gaining 15% but lagging due to declining deposits and loss of a government contract, leading to a "hold" rating. Q4 results showed weak deposit growth but impressive pricing actions, with a shift from brokered to core deposits, aiding margin expansion. Loan demand remains tepid, but credit quality is solid with limited commercial real estate exposure, and the bank benefits more from falling rates. Despite some downside risks, CMA stock is trading around fair value, with limited upside but a secure dividend, justifying an upgrade to "hold". Read the full article on Seeking Alpha
Seeking Alpha Nov 15

Comerica: Too Much Optimism Given Deposit Headwinds (Downgrade)

Summary Comerica's shares have rallied 60% over the past year, but the recent gains appear overdone given ongoing deposit weaknesses. Despite a solid capital position and potential regulatory benefits, CMA faces challenges with declining noninterest-bearing deposits and higher deposit costs. The bank's net interest margin is pressured by unfavorable deposit mix and declining loans, with limited near-term earnings growth expected. With a full valuation at 13x earnings and a 10% downside risk, I recommend selling Comerica shares to capitalize on the recent rally. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:CMA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20283,412598N/AN/A1
12/31/20273,519681N/AN/A7
12/31/20263,426635N/AN/A9
12/31/20253,266691N/AN/AN/A
9/30/20253,23469024125N/A
6/30/20253,2156921,3411,444N/A
3/31/20253,2347059591,079N/A
12/31/20243,195671448601N/A
9/30/20243,1615351,8992,077N/A
6/30/20243,246602667850N/A
3/31/20243,313668412584N/A
12/31/20233,5038541,0981,251N/A
9/30/20233,7201,169609726N/A
6/30/20233,7951,2681,2021,297N/A
3/31/20233,7231,2571,7241,810N/A
12/31/20223,4741,122556638N/A
9/30/20223,2621,001392470N/A
6/30/20223,102913203279N/A
3/31/20223,167979-304-235N/A
12/31/20213,3511,140564634N/A
9/30/20213,3271,134335413N/A
6/30/20213,2351,088102187N/A
3/31/20212,931884306388N/A
12/31/20202,375482849928N/A
9/30/20202,426534866941N/A
6/30/20202,5286151,3231,409N/A
3/31/20202,7577951,6641,749N/A
12/31/20193,2751,1951,0041,090N/A
9/30/20193,3211,232N/A1,518N/A
6/30/20193,3471,258N/A1,427N/A
3/31/20193,4051,285N/A1,298N/A
12/31/20183,3291,227N/A1,616N/A
9/30/20183,3001,031N/A1,202N/A
6/30/20183,264939N/A1,049N/A
3/31/20183,156817N/A1,039N/A
12/31/20173,094738N/A1,085N/A
9/30/20172,968789N/A950N/A
6/30/20172,877713N/A908N/A
3/31/20172,782614N/A658N/A
12/31/20162,600473N/A486N/A
9/30/20162,552425N/A601N/A
6/30/20162,502411N/A712N/A
3/31/20162,469442N/A772N/A
12/31/20152,577515N/A865N/A
9/30/20152,576548N/A737N/A
6/30/20152,544566N/A687N/A
3/31/20152,538581N/A763N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: CMAFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-1.3% pro Jahr).

Ertrag vs. Markt: CMAFür die nächsten 3 Jahre wird ein Rückgang der Gewinne prognostiziert (-1.3% pro Jahr).

Hohe Wachstumserträge: CMAFür die nächsten 3 Jahre wird mit einem Rückgang der Erträge gerechnet.

Einnahmen vs. Markt: CMADie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.7% pro Jahr).

Hohe Wachstumseinnahmen: CMADie Einnahmen des Unternehmens (2% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.


Wachstumsprognosen für den Gewinn je Aktie


Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: CMADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (9.4%).


Wachstumsunternehmen entdecken

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/02/03 19:54
Aktienkurs zum Tagesende2026/01/30 00:00
Gewinne2025/12/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Comerica Incorporated wird von 32 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Kevin HealArgus Research Company
David GeorgeBaird
Kevin St. PierreBernstein